Statement regarding recall of valsartan in generic medicines in Canada
Jul 13, 2018
Dorval, Quebec, July 13, 2018 - Novartis Pharmaceuticals Canada Inc. (Novartis Pharmaceuticals) is seeking to provide clarity on the recent Health Canada recall of several generic medications containing valsartan. This recall does not include any Novartis Pharmaceuticals products containing valsartan, namely Diovan®, Diovan/HCT® and Entresto®.
The Novartis Pharmaceuticals products containing valsartan are not sourced from the same supplier where an impurity was identified during qualification tests.
We are working diligently to support the continuity of treatment for patients who are prescribed Novartis Pharmaceuticals medicines. The company takes its commitment to patients very seriously and is monitoring this situation very closely.
To see the full list of products and manufacturers implicated by this recall, please visit the Health Canada Recalls and safety alerts website here.
For any inquires related specifically to Diovan®, DiovanHCT® and Entresto®, please contact our Medical Information Department at 1-800-363-8883 or [email protected].